Clinical Trials Browser

Active not recruiting × Interventional × Advanced Rare Tumours × Clear all

NCT01396408 2025-03-18

A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours

Phase 2 Active not recruiting

Advanced Rare Tumours